(CLX) The Clorox Company BCG Matrix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(CLX) The Clorox Company Bundle
Download Your Competitive Advantage
This The Clorox Company BCG Matrix helps you see how the company’s products or business units may rank across Stars, Cash Cows, Question Marks, and Dogs for strategy and capital allocation. The content on this page is a real preview of the actual analysis, so you can review the format and findings before buying. Purchase the full version to get the complete ready-to-use report instantly.
Stars
Brita water filtration
Brita is a Star in The Clorox Company BCG Matrix because it benefits from water-quality and plastic-reduction demand, while Clorox keeps strong grocery, mass, and e-commerce reach behind the brand. In Clorox fiscal 2025, net sales were $7.1 billion, showing the scale supporting Brita’s shelf and online visibility. Brita remains one of the clearest growth assets in the portfolio.
Burt's Bees natural personal care
Burt's Bees fits Clorox's Stars bucket because clean beauty and natural personal care still drive demand, and the brand has broad U.S. retail reach and strong repeat buying. In Clorox's FY2025, net sales were about $7.0 billion, showing the company still has scale to support this brand. Its natural positioning gives it room to keep gaining share if the category stays hot.
CloroxPro disinfecting products
CloroxPro is a Star because it sells into professional cleaning, foodservice, and facility channels, which repeat orders more often than one-time consumer buys. It also rides on Clorox’s strong disinfecting name, which helps pricing and trust. In Clorox Company’s FY2025, net sales were about $7.1 billion, and this B2B mix supports steadier demand than retail alone.
Clorox Healthcare
Clorox Healthcare sits in a sticky, growth-led niche: hospitals and clinics keep buying disinfection products because infection control is non-optional. In FY2025, The Clorox Company reported about $6.5 billion in net sales, and the healthcare line benefits from that steady demand even when consumer volumes soften.
- Hospital demand is structurally recurring.
- Disinfection is hard to switch and win.
- Healthcare spend supports premium pricing.
VMS portfolio RenewLife, Natural Vitality, NeoCell, Rainbow Light
The Clorox Company’s VMS brands—RenewLife, Natural Vitality, NeoCell, and Rainbow Light—sit in a higher-growth wellness pool, but they still need more scale. Clorox reported about $7.1 billion in fiscal 2025 sales, so these labels are still small versus the core business.
RenewLife and Natural Vitality lean into digestive health and magnesium, while NeoCell and Rainbow Light cover collagen and multivitamins. That spread gives The Clorox Company exposure to several fast-moving subcategories, but share gains depend on steady product launches and stronger promotion.
- High-growth category, low current scale
- Broad exposure across key VMS niches
- Innovation and promotion still matter most
Clorox’s Star Brands Are Driving Growth in High-Demand Niches
Stars in The Clorox Company BCG Matrix are Brita, Burt's Bees, CloroxPro, and Clorox Healthcare. They sit in higher-growth niches with repeat demand, and Clorox's FY2025 net sales were about $7.1 billion, giving these brands strong route-to-market support. The VMS brands also have growth upside, but they still need scale.
| Brand | Star case | FY2025 sales |
|---|---|---|
| Brita | Water quality, plastic reduction | About $7.1B company sales |
What is included in the product
Detailed Word Document
Clorox BCG Matrix maps its brands to Stars, Cash Cows, Question Marks, and Dogs to guide invest, hold, or divest decisions.
Editable Excel File
Clorox BCG Matrix: one-page quadrant view to quickly spot winners, cash cows, and laggards.
Reference Sources
Provides a concise source trail for The Clorox Company, strengthening credibility and speeding informed decisions.
Cash Cows
Clorox bleach
Clorox bleach is The Clorox Company’s flagship brand and the heart of its identity. In FY2025, The Clorox Company reported about $7.1 billion in net sales, and bleach stayed a dependable cash source in a mature, low-growth category. Demand is steady because households keep using bleach for cleaning, whitening, and disinfection. That mix of brand strength and repeat buys makes it a classic cash cow.
Glad bags and wraps
Glad bags and wraps fit the Cash Cows box because they are a mature, repeat-buy franchise in household disposal and food storage. The Clorox Company reported about $7.1 billion in fiscal 2025 sales, and stable brands like Glad help support that cash flow. In a low-growth, high-repeat category, Glad keeps generating cash with limited brand reinvestment.
Kingsford charcoal
In Clorox’s FY2025, net sales were about $7.1 billion, and Kingsford stayed a cash cow because charcoal grilling is mature, seasonal, and low-growth. Its U.S. brand leadership and repeat summer demand support steady cash generation, even when volume is flat.
Hidden Valley dressings and ranch
Hidden Valley is a large, established condiment franchise inside The Clorox Company"s Lifestyle segment, and ranch plus salad dressing sit in mature categories with limited growth. That makes it a cash cow: steady demand, strong shelf presence, and recurring cash flow that helps fund other brands. In Clorox"s FY2025 base, Lifestyle remained a core profit engine, even as category growth stayed low.
- Large, mature franchise
- Ranch is low-growth
- Steady cash generation
- Supports Lifestyle profits
Fresh Step cat litter
Fresh Step is a Cash Cow for The Clorox Company: cat litter is a repeat-buy need, so demand stays steady even when growth is soft. In fiscal 2025, The Clorox Company generated about $7.1 billion in net sales, and brands like Fresh Step help support that cash flow with loyal buyers and stable margins.
- Recurring pet-care demand
- Loyal, repeat customers
- Stable, low-growth category
- Cash flow and margin support
Clorox’s FY2025 Cash Cows Kept the Company’s Earnings Engine Running
In The Clorox Company’s FY2025, cash cows were its mature, repeat-buy brands, led by Clorox bleach, Glad, Kingsford, Hidden Valley, and Fresh Step. The Clorox Company reported about $7.1 billion in net sales, and these brands kept generating steady cash in low-growth categories. Their strong shelf presence and loyal buying patterns help fund innovation and support margins.
| Brand | Cash Cow Signal |
|---|---|
| Clorox bleach | Stable, repeat demand |
| Glad | Mature household use |
| Kingsford | Seasonal but steady cash |
| Hidden Valley | Large, low-growth franchise |
| Fresh Step | Recurring pet-care buys |
What You See Is What You Get
The Clorox Company Reference Sources
This preview shows the exact BCG Matrix report you’ll receive for The Clorox Company after purchase. No demo content or placeholder pages—just the full, ready-to-use document. Download it instantly and use it for analysis, presentations, or strategic planning with confidence.
Dogs
Formula 409 all-purpose cleaner
Formula 409 all-purpose cleaner sits in a mature, crowded cleaning aisle, while The Clorox Company posted about $7.1 billion in fiscal 2025 net sales, led by stronger franchise brands. With limited evidence of high growth or share gains versus bigger engines like Clorox disinfecting and Glad, Formula 409 fits closer to a BCG dog than a growth driver.
Tilex bathroom cleaner
Tilex bathroom cleaner fits the Dogs bucket in The Clorox Company BCG Matrix: it serves a niche in a slow-growth cleaning aisle, where demand is steady but not fast expanding.
The Clorox Company reported fiscal 2025 net sales of $7.1 billion, but Tilex is not disclosed as a major growth driver, which points to limited incremental capital priority.
In a mature bathroom-cleaner market, Tilex can defend shelf space and cash flow, but it is unlikely to justify heavy new investment unless Clorox sees a clear share gain.
Liquid-Plumr drain care
Liquid-Plumr sits in a narrow drain-care niche with limited category growth, so it does not drive The Clorox Company’s main earnings engine. The Clorox Company posted about $7.1 billion in fiscal 2025 net sales, but Liquid-Plumr is still a small, support brand rather than a portfolio leader. That fits a low-share, low-growth "dog" in the BCG Matrix.
Clorinda regional household cleaner
Clorinda is a Latin America legacy brand for The Clorox Company, and in price-heavy, fragmented cleaning markets it likely fits the Dogs box if growth and share stay modest. Its role is mainly defensive: keep niche shelf space, but not chase big capital. A Dog label is strongest when a brand’s growth stays near zero and its economics stay weak versus the rest of the portfolio.
- Legacy regional brand, not a growth engine
- Fragmented market keeps pricing pressure high
- Low share plus weak growth = Dog
Poett regional cleaning and home-care
In FY2025, The Clorox Company posted about $7.1 billion in net sales, but Poett stays a small regional home-care label with constrained scale. In a BCG lens, that profile fits Dog territory: it needs support, yet it does not move the company’s growth mix.
- Localized brand
- Low scale
- Support heavy
- Weak growth impact
Clorox’s Dog Brands: Cash-Flow Defenders, Not Growth Drivers
The Dogs brands in The Clorox Company portfolio are low-growth, low-share assets that mainly defend shelf space, not drive expansion. In fiscal 2025, The Clorox Company reported about $7.1 billion in net sales, but brands like Formula 409, Tilex, Liquid-Plumr, Clorinda, and Poett remain small or mature. They can still support cash flow, yet they rank low for new capital.
| Dog brands | BCG read |
|---|---|
| Formula 409, Tilex, Liquid-Plumr, Clorinda, Poett | Low growth, low share, cash defense |
Question Marks
Scentiva premium cleaners
Scentiva fits the Question Mark box for The Clorox Company: it serves a premium, scent-forward niche with growth upside, but it is not a share leader. The Clorox Company said net sales were $7.09 billion in fiscal 2025, so smaller bets like Scentiva need clear capital and shelf support to scale. If investment stalls, it can stay niche instead of becoming a core brand.
NeoCell collagen
NeoCell collagen fits the question mark box: collagen is a fast-growing wellness niche, but the supplement aisle is crowded, so share is hard to win. Clorox Company reported FY2025 net sales of about $7.1 billion, but NeoCell’s scale inside that mix is still not a clear profit driver. It needs more spend or a tighter focus to turn growth into share.
Rainbow Light multivitamins
Rainbow Light multivitamins fit the Question Mark box: the multivitamin market is still large and crowded, but Clorox does not have clear share leadership here. Rainbow Light gives Clorox growth exposure, yet its value is limited unless the brand scales faster and wins more shelf and online space. If Clorox cannot lift velocity and penetration, it stays a low-visibility bet.
Natural Vitality magnesium
Natural Vitality magnesium fits as a Question Mark in The Clorox Company BCG Matrix: magnesium and stress-wellness demand is rising, but the brand still fights heavy competition. Clorox’s FY2025 net sales were about $7.1 billion, so Natural Vitality needs more support to turn category relevance into real share.
High-growth niche, weak share, needs investment.
Ever Clean premium cat litter
Ever Clean is a Question Mark for The Clorox Company: it gives the firm international exposure in premium cat litter, where pet-care demand is still growing outside the U.S., but its share is much smaller than Clorox's U.S. pet core.
The brand can win in higher-end markets, yet it needs more investment to scale, so it fits a low-share, higher-growth profile.
- Premium, international, smaller-share bet
- Growth tailwinds, but not a cash cow
- Needs capital to build share
Clorox’s Question Marks Need Investment to Win Share
Clorox Company’s Question Marks are small-growth bets with weak share, so they need funding to scale or they stay niche. In fiscal 2025, Clorox Company reported net sales of $7.09 billion, which shows these brands sit inside a large base but still need sharper investment to matter more. Ever Clean adds premium pet-care reach, while Scentiva, NeoCell, Rainbow Light, and Natural Vitality all need more shelf, media, or online pull.
| Brand | BCG role | Why |
|---|---|---|
| Scentiva | Question Mark | Premium niche, low share |
| NeoCell | Question Mark | Fast-growing collagen, crowded aisle |
| Rainbow Light | Question Mark | Large market, weak leadership |
| Natural Vitality | Question Mark | Rising demand, heavy competition |
| Ever Clean | Question Mark | Premium pet-care, needs scale |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.